Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acquired resistance to cancer chemotherapy.

× No keyword cloud information.

17 in total

Review 1. Proliferation-dependent cytotoxicity of anticancer agents: a review.

Authors: F Valeriote; L van Putten
Journal: Cancer Res Date: 1975-10 Impact factor: 12.701

Review 2. Multidrug-resistance phenotype in Chinese hamster ovary cells.

Authors: V Ling; N Kartner; T Sudo; L Siminovitch; J R Riordan
Journal: Cancer Treat Rep Date: 1983-10

3. Unstable methotrexate resistance in human small-cell carcinoma associated with double minute chromosomes.

Authors: G A Curt; D N Carney; K H Cowan; J Jolivet; B D Bailey; J C Drake; K S Chien Song; J D Minna; B A Chabner
Journal: N Engl J Med Date: 1983-01-27 Impact factor: 91.245

4. Gene transfer in intact animals.

Authors: M J Cline; H Stang; K Mercola; L Morse; R Ruprecht; J Brown; W Salser
Journal: Nature Date: 1980-04-03 Impact factor: 49.962

5. Interactions between tumor subpopulations affecting their sensitivity to the antineoplastic agents cyclophosphamide and methotrexate.

Authors: B E Miller; F R Miller; G H Heppner
Journal: Cancer Res Date: 1981-11 Impact factor: 12.701

6. Amplified dihydrofolate reductase genes in unstably methotrexate-resistant cells are associated with double minute chromosomes.

Authors: R J Kaufman; P C Brown; R T Schimke
Journal: Proc Natl Acad Sci U S A Date: 1979-11 Impact factor: 11.205

7. Molecular identification of a human DNA repair gene following DNA-mediated gene transfer.

Authors: J S Rubin; A L Joyner; A Bernstein; G F Whitmore
Journal: Nature Date: 1983 Nov 10-16 Impact factor: 49.962

8. High-dose intravenous melphalan for plasma-cell leukaemia and myeloma.

Authors: T J McElwain; R L Powles
Journal: Lancet Date: 1983-10-08 Impact factor: 79.321

Review 9. Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.

Authors: G Bonadonna
Journal: Cancer Res Date: 1982-11 Impact factor: 12.701

10. Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma.

Authors: J T Isaacs; D S Coffey
Journal: Cancer Res Date: 1981-12 Impact factor: 12.701

2 in total

1. Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A.

Authors: H M Coley; P R Twentyman; P Workman
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

2. 9-alkyl anthracyclines. Absence of cross-resistance to adriamycin in human and murine cell cultures.

Authors: C A Scott; D Westmacott; M J Broadhurst; G J Thomas; M J Hall
Journal: Br J Cancer Date: 1986-05 Impact factor: 7.640

2 in total